OBI Pharma, Inc. to Present at the 39th J.P. Morgan Healthcare Conference

On January 6, 2021 OBI Pharma, Inc., a Taiwan biopharma company (TPEx: 4174), reported that Tillman Pearce, MD., Chief Medical Officer, will present a company and clinical development overview at the 39th Annual J.P. Morgan Digital Healthcare Conference on Monday, January 11, 2021 at 11:00 a.m. EST/ 8:00 a.m. PST (Press release, OBI Pharma, JAN 6, 2021, View Source [SID1234573596]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The presentation slides will be available online at www.obipharma.com on January 12, 2021.